Virtual Medicinal Product (VMP) - Nevirapine 50mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Nevirapine 50mg/5ml oral suspension | Start Date 29-05-2003 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J05AG01
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 05030100 | Start Date 04-04-2022 | End Date |
| Previous BNF 05030100 | Start Date 24-02-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 41766711000001102 | 09-05-2023 | |
| 324865007 | 29-05-2003 | 08-05-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Nevirapine hemihydrate | Based on Base Substance | Nevirapine | 10 mg | 1 ml |
Name
Nevirapine hemihydrate
Basis of strength description
Based on Base Substance
BOSS
Nevirapine
Strength and UOM (Nmr)
10
Strength and UOM (Dmr)
1
Parent Products
-
VTMNevirapine
-
VMP(Current) Nevirapine 50mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 240 ml |